SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-048303
Filing Date
2024-04-25
Accepted
2024-04-25 16:08:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A pstx_defa14a_2024.htm DEFA14A 20280
2 GRAPHIC img123732085_0.jpg GRAPHIC 1303158
3 GRAPHIC img123732085_1.jpg GRAPHIC 60807
  Complete submission text file 0000950170-24-048303.txt   1898307
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39376 | Film No.: 24876331
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)